Kwon Paul 4/A
4/A · Menlo Therapeutics Inc. · Filed Aug 7, 2019
Insider Transaction Report
Form 4/AAmended
Kwon Paul
Chief Scientific Officer
Transactions
- Award
Restricted Stock Units
2019-07-29+80,300→ 396,812 total→ Common Stock (80,300 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock.
- [F2]The RSUs shall vest in two (2) equal annual installments beginning July 29, 2020, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- [F3]Not Applicable